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Summary
Tumor necrosis factor a, granulocyte colony-stimulating factor, granulocyte/macrophage colony-
stimulating factor, and formyl peptide were each found to cause a twofold increase in expression
of CD14 on the surface of polymorphonuclear leukocytes (PMN). Upregulation of CD14 was
complete by 20 min and thus appeared to result from expression of preformed stores ofprotein.
The CD14 on the surface ofPMN was shown to serve two biological functions. It bound particles
coated with complexes oflipopolysaccharide (LPS) and LPS binding protein (LBP). This binding
activity was enhanced by agonists that upregulated CD14 expression and may serve in the clearance
of Gram-negative bacteria opsonized with LBP. Interaction of CD14 with LPS in the presence
of LBP or serum also caused a dramatic, transient increase in the adhesive activity of CR3
(CD11b/CD18) on PMN. Enhanced activity of CR3 and other members of the CD11/CD18
family underlies many of the known physiological responses ofPMN to LPS and may be a central
feature of the in vivo responses of PMN to endotoxin.
Bacterial LPS (endotoxin) is known to have profound physio-
logical effects on PMN both in vivo and in vitro. Animals
respond to intravenous LPS with a rapid fall in the number
of circulating PMN and a concomitant accumulation ofPMN
in the lungs (1). Isolated PMN respond to LPS with increased
adhesion to protein-coated surfaces (2), enhanced ability to
mount an oxidative burst (3), and enhanced microbicidal
powers (4). Many of these responses to LPS appear to depend
at least in part on enhanced function of the three members
of the CD11/CD18 family of adhesion-promoting receptors
(LFA1, CR3, and p150,95, also known as the 02 or leuko-
cyte integrins) on the surface of PMN . Adhesion of PMN
to endothelium requires the participation ofCDII/CD18 mol-
ecules (5-7), and blockade ofCD18 with mAbs prevents ac-
cumulationofPMN in the lungs ofendotoxin-treated animals
(8) . Adhesion ofPMN to protein-coated glass (5), enhanced
oxidative burst in response to soluble agonists (9), and microbi-
cidal activity (5) are also dependent on increased CD11/CD18
function. Here, we directly measure the effect of LPS on the
adhesive function ofCR3 (CD11b/CD18) and describe a dra-
matic enhancement of its adhesive activity by complexes of
LPS with proteins from the serum.
Recent studies have described a novel mechanism by which
mononuclear cells may respond to LPS (10, 11). LPS is first
bound by the serum protein LPS binding protein (LBP)l,
and the resulting LPS-LBP complex is then recognized by
CD14, a 55-kD glycoprotein that is strongly expressed on
monocytes and macrophages. LBP and CD14 serve two phys-
iological roles. These proteins act as opsonin and opsonic
receptor, respectively, to promote the phagocytic uptake of
bacteria or LPS-coated particles by macrophages (12). They
also dramatically enhance the ability of mononuclear cellsto
synthesize TNF in response to endotoxin. Addition of LBP
speeds the synthesis of TNF and enables a response to doses
of LPS 100-fold lower than are otherwise required (10).
Blockade of CD14 with mAbs prevents the synthesis ofTNF
in response to ng/ml concentrations of LPS by monocytes
in the presence of plasma (11).
We have asked whether CD14 and LBP also participate
in the physiological responses of PMN to LPS. Though these
cells express x+10-fold less CD14 than monocytes, we find
that the CD14 on PMN is capable of mediating the binding
ofLPS-coated erythrocytes (ELPS) opsonized with LBP. We
t Abbreviations used in this paper. ELPS, LPS-coated erythrocytes; NLLP,
formyl-norleucyl-leucyl-phenyhilanine; GCSF, granulocyte CSF; GM-CSF,
granulocyte/macxophage CSF; LPB, LPS binding protein; NIM, neutrophil
isolation medium.
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that is rapidly upregulated upon stimulation with TNF-a,
granulocyte CSF (G-CSF), granulocyte/macrophage CSF
(GM-CSF), and formyl peptide, and that thenewlyexpressed
CD14 serves in recognition ofparticlesopsonizedwith LPS-
LBP complexes . In addition, LBP and CD14 appear to play
a critical role in responsesofPMNto LPS, since theenhance-
ment ofCR3 activity in response to LPS requires serum or
the serum protein LBP, and is completely blocked by anti-
bodies against CD14 .
Materials and Methods
Reagents.
￿
The recombinant human cytokines TNF-a(Genen-
tech, So . San Francisco, CA), GM-CSF (Amgen, Thousand Oaks,
CA), and G-CSF (Amgen) were gifts from the manufacturers .
Formyl-norleucyl-leucyl-phenylalanine (fNLLP)and aprotininwere
purchased from SigmaChemical Co. (St . Louis, MO), andpyrogen-
free human serum albumin was from Armour Pharmaceuticals
(Kankakee, IL). LPS (Re 595) was from List Biochemicals (Camp-
bell, CA) .
Human LBP was purified from fresh frozen normal human
plasma by publishedmethods (13), and rabbit LBPwas a gift from
Dr. R. Ulevitch (La Jolla, CA). mAbs 3C10 (14) and 26ic (15)
directed againstCD14, and W6/32 (16) directed againstHLA, were
purified to homogeneity by chromatography on protein G .
Cells. PMN for rosetting experiments were isolated from
normal humanbloodon Ficoll gradients (17). PMN forflow cytom-
etry were isolated using neutrophil isolation medium (NIM; Los
Alamos Diagnostics, LosAlamos, NM). 8ml ofwhole heparinized
blood was layered on 4ml ofNIMandcentrifuged 30 min at 400
g at ambient temperature. The layercontainingPMNwas removed
to a separate tube and contaminating erythrocytes were removed
by hypotonic lysis . PMN isolated by either method were suspended
to 2 x 106/ml in Dulbecco's PBS containing 0.5 mg/ml HSA, 0.3
U/ml aprotinin, and 3mM glucose (HAP buffer) and were used
within 1 h of isolation .
Sheep erythrocytes were coated with LPS or C3bi to yieldELPS
or EC3bi by methods previously described (12, 18) . The dose of
LPS used to prepare the ELPS was 1 wg/4 x 10' erythrocytes .
Assays.
￿
To measure the binding of erythrocytes coated with
LPS-LBP complexes to human PMN, monolayers of cells were
formed by adding 10° PMN to Terasaki culture wells and in-
cubating 30 min at 37°C . Cells were washed with PBS containing
1mM EDTA and incubatedwith 5 x 10 5 ELPS and 1 Fg/mlLBP
for 15 min at 0°C, then warmed to 210C for 15 min . Removal
ofdivalent cations eliminates contributions ofCD18 molecules to
the binding of ELPS (18) but does not affect binding of LPS-LBP
complexes to macrophages (12) . Cultures were inverted for 20 min
to allow gravity to gently remove nonadherent erythrocytes from
thePMN. Attachment of erythrocytes was scored by phase con-
trast microscopy and data are presented as attachment index, the
number of erythrocytes bound per 100PMN.
Theadhesive activity ofCR3 was measured by adding 5 x 105
EC3bi to monolayers ofPMNandincubating for30 min at 37°C.
Nonadherent EC3bi were removed by vigorous washing, and the
attachment index was enumerated as above .
Flow Cytometry.
￿
Isolated cellswere exposed to mAb (5 Etg/ml)
for 15 min at 0°C, washed, and incubated with fluoresceinated
affinity-purified goat anti-mouse IgG F(ab')2 (7 hg/ml; Tago Inc.,
Burlingame, CA) for 45 min at 0°C . Fluorescence was measured
on a FACScana cell analyzer (Becton Dickinson & Co., Mountain
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View, CA) . mAbOKT3, directed against CD3, was used as a nega-
tive control, and themean fluorescence channel ofcells stained with
OKT3 was subtracted from the experimental values .
In some experiments, washed cells from whole blood were stained
as described above. Erythrocytes were then removed with FRCS®
lysing buffer (BectonDickinson&Co.), andPMN andmonocytes
were gatedby their light-scattering properties. Experiments with
fluorescent standards indicated that our measurements of mean
fluorescence were linearly related to the number of fluorescein mol-
ecules per cell.
Results
PMNContain an Intracellular Pool ofCD14 .
￿
Flow cytom-
etry on blood leukocytes indicated that themean fluorescence
obtained after staining PMN with anti-CD14 was -10%
(9.78 ± 6.8%, n = 8) of that observed on monocytes in
the same blood sample. Approximately 50,000 CD14 mole-
cules are expressed per monocyte (14), and PMN thus ex-
press -5,000 CD14 per cell.
Incubation of isolatedPMN with the cytokines TNF-a,
G-CSF, or GM-CSF, or with thechemotactic peptide fNLLP
caused a dose-dependent 1.6-2.6-fold increase in the expres-
sion ofCD14 on PMN (Fig. 1, Table 1) . The dose of each
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Figure 1 .
￿
Cytokines increase expressionof CD14on the surface ofPMN.
PMNwere incubated at 37°C for either 30 min with increasing concen-
trations of fNLLP or TNF, or 60 minwith increasing concentrations of
G-CSF ofGM-CSF before staining with the anti-CD14mAb 3C10 . Par-
allel samples were stained with mAb W6/32 and one example is shown
in the G-CSF panel (filkd triangles) . In all experiments the expression of
HLA either remained the same or declined upon treatment with agonists.
The panels shown are from separate experiments and are representative
of at least three individual experiments.
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~ePMN were incubated with agonists and stained as in Fig. 1 . The fold
increase in expression of CD14 is presented as mean ± SEM.
stimulant required for half-maximal upregulation of CD14
(Fig. 1) was consistent with the known potencies of these
agonists in other assays ofPMN function. Upregulation of
CD14 was rapid and complete within 20 min of adding the
stimulus (Fig. 2), suggesting that new synthesis of CD14
is not required for the increased expression . Parallel studies
on the expression of HLA showed no increase, suggesting
that CD14 is selectively externalized from an intracellular pool .
Quantitatively similar upregulation ofCD14 expression was
measured with 3C10, an anti-CD14 mAb that blocks the
ligand-binding site, or with 26ic (data not shown), a mAb
that does not block the ligand-binding site (11) . It is there-
fore unlikely that the apparent levels ofCD14 expression were
altered by the presence of ligand on the CD14 glycoprotein .
CD14 on PMN Mediates Binding of LPS-LBP Com-
plexes. ELPS did not bind appreciably to resting PMN, but
addition of 1 P.g/mlLBP enabled binding (Table 2) . The ex-
periment shown in Table 2 was done in the absence of diva-
lent cations to eliminate a small contribution ofCD18 mole-
cules to the binding of ELPS, but qualitatively similar results
were obtained in the presence of divalents (data not shown) .
Additional experiments showed that pretreatment of thePMN
with LBP did not enable the leukocytes to bind ELPS, but
pretreatment of ELPS and LBP resulted in strong binding
to PMN (data not shown) . Thus, as previously described for
macrophages (12), PMN recognize the stable complexes of
Figure 2.
￿
Time course of the
increase in expression ofCD14 in
response to agonists. PMN were
incubated for a total of60 min at
37°C with G-CSF (800pM;filled
curies), GM-CSF (800 pM; open
circles), fNLLP (10 nM ; filled
squares), orTNF (600 pM ; open
squares) added for the indicated
times.PMNwere stained with the
iJ
￿
anti-CD14 mAb 3C10. Parallel
samplestreatedwith G-CSF were
stained with mAb W6/32 (filled
triangles) . The data are from sepa-
rate experiments and are represen-
tative of at least three individual
Time (min)
￿
experiments.
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PMN were incubated in Terasaki wells for 30 min with the cytokines
shown, and the monolayers were washed . 10 pg/ml of the anti-CD14
mAb3C10 was added to some wells at this point . ELPS were then added
in the presence or absence of 0.5 t~g/ml human LBP. The preparations
were incubated at 0°C for 15 min, then at 21°C for 15 min, and the
attachment index was tabulated . This experiment is representative of more
than five separate studies . Similar results were obtained with both hu-
man and rabbit LBP .
LBP with LPS formed on the surface of an erythrocyte, not
soluble LBP.
Recognition ofLPS-LBP complexes byPMN occurs via
CD14, since the LBP-dependent binding ofELPS to PMN
was completelyblocked by amAb directed againstCD14 (Table
2). Furthermore, treatment ofPMN with concentrations of
fNLLP, TNF, G-CSF, or GM-CSF that caused an approxi-
mate doubling in the expression of cell surface CD14 also
caused an approximate doubling in the LBRdependent binding
of ELPS (Table 2) . Both the time course and dose depen-
dence ofcytokine-induced increases in binding activity were
congruent with increases in expression of CD14 shown in
Figs . 1 and 2 (data not shown), and the enhanced binding
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Figure 3.
￿
LPS-LBP complexes stimulateCR3 activity. PMN were in-
cubated for 30 min with the indicated concentrations of LPS in either
the absence (open circles) or presence (filled circles) of 1 Elg/ml humanLBP
The monolayers were then washed, EC3bi were added, and the attach-
ment index was determined after a 30-min incubation at 37°C. Results
are representative ofthree separate experiments. Identical results were ob-
tained with rabbit LBP.
Table 1. Increase in Expression ofCD14 in Response to Agonists Table 2. CD14 on PAIN
with LPS-LBP Complexes
Mediates Binding of Particles Coated
Agonist Fold increase in expression
ELPS + LBP
G-CSF (800 pM) 1.6 ± 0.1 (n = 3) Cytokine ELPS ELPS + LBP + 3C10
GM-CSF (800 pM) 1.7 ± 0.3 (n = 3)
NLLP (1 p,M) 2.6 ± 0.2 (n = 3) None 8.3 81 4.8
TNF (600 pM) 2 .0 ± 0.1 (n = 5) GM-CSF (70 pM) 27 152 6.3
G-CSF (70 pM) 2.5 138 2.8caused by cytokines was completely inhibited by anti-CD14
(Table 2) . These data indicate that CD14 on PMN is capable
of mediating the opsonic interaction ofLPS-LBP complexes
with PMN and that the intracellular pools ofCD14 expressed
in response to cytokines contribute to this activity.
LPS-LBP Complexes Activate the Binding Activity ofCR3.
We examined the ability of LPS to modulate CD18-dependent
adhesivity by measuring the interaction of the numerically
dominant CD18 molecule (CR3, CDllb/CD18) on PMN
with its best-characterized ligand: C3bi attached to erythro-
cytes (EC3bi). As previously reported (19), unstimulated PMN
have negligible ability to bind EC3bi. We foundthat extremely
high concentrations ofpurified LPS (100 ng/ml) caused a slight
activation ofCR3, as evidenced by enhanced binding ofEON
to PMN (Fig. 3). However, addition of LBP to the incuba-
tions enabled cells to respond to LPS with dramatically en-
hanced CR3 activity. LBP caused a >100-fold enhancement
of sensitivity to LPS with half-maximal responses observed
at <1 ng/ml LPS. Similar enhancement of CR3 binding ac-
tivity in response to LPS was obtained when 1% human serum
or plasma was substituted for purified LBP (data not shown).
LBP or plasma in the absence of LPS had no effect on CR3
activity.
Activation of CR3 by LPS-LBP complexes was maximal
after 35 min, but declined upon further incubation (Fig. 4).
Such transient activation of CR3 has been previously noted
for the agonists PMA (19), C5a (7), TNF (7), and fNLLP
(S.D. Wright and P.A. Detmers, unpublished observations),
and may underlie the transient binding of motile cells with
the substrate over which they are migrating. Previous studies
indicate that agonists such as PMA or fNLLP enhance the
adhesive activity of CR3 by two mechanisms. Exocytosis of
specific granules results in a two- to threefold rise in the ex-
pression ofCR3, and simultaneous qualitative changes cause
a 5-10-fold increase in the adhesive activity of existing CR3
(7, 19-22). LPS-LBP complexes caused only a modest rise
(N40%) in cell surface CR3 (Table 3), and thus qualitative
Time of incubation with Re LPS (min)
Figure 4.
￿
LPS-LBPcomplexescause transient activation of CR3. PMN
were incubated at 37°C for 50 min. At intervals during this incubation,
LPS (1 ng/ml) or LPS-LBP complexes (1 ng/ml LPS, 1 Wg/ml LBP) were
added so as to provide the indicated periods of stimulation with these
agonists. Themonolayerswerewashed, and attachment ofEC3bi was then
determined. Results are representative of three separate experiments.
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Table 3.
￿
LPS-LBP Complexes Cause Little Increase Expression
A suspension of 2 x 106 PMN/ml in HAP buffer was incubated for 30
min at 37°C with LPS (1 ng/ml), LBP (1 ug/ml rabbit LBP), or both
LPS and LBP. Cells were then washed, stained with the indicated mAbs,
and the mean fluorescence was determined. Results represent averages
of duplicate determinations, and the experiment shown is representative
oftwo studies. The backgroundfluorescence determined with mAb OKT3
(or without primary antibody) was 4.5 and was subtracted from the read-
ings shown.
changes in existing CR3 may be principally responsible for
the increased adhesive activity. Interestingly, LPS-LBP com-
plexes did not cause upregulation ofCD14 at the cell surface.
Addition of anti-CD14 mAb completely blocked activa-
tion ofCR3 by LPS-LBP complexes, but control mAbs had
no effect (Table 4). Similarly, anti-CD14 completelyblocked
the responses to LPS measured in the presence ofwhole serum
(data not shown) . These observations suggest that CD14 is
required for activation of CR3 by LPS.
Discussion
While CD14 is expressed on the surface of resting PMN,
stimulation ofcells with TNF-a, G-CSF, GM-CSF, or fNLLP
caused a rapid twofold increase in its expression. These ob-
servations suggest that new CD14 is deployed on the cell
Table 4.
￿
Anti-CD14 Inhibits Activation of PMN
by LPS-LBP complexes
Activation of the Adhesive Capacity of CR3 on Neutrophils by Endotoxin
PMN were incubated for 15 min at 37°C with the antibodies indicated.
LPS (1 ng/ml) or LPS/LBP complexes (1 ng/ml LPLS, 1 jig/ml LBP)
were added, and incubation was continued for 30 min at 37°C. EC3bi
were then added and, after 30 min at 37°C, the attachment index was
measured. This experiment is representative of four separate studies.
of CR3 on PMN
Stimulant CR3 (OKM10)
Mean fluorescence
HLA (W6/32) CD14 (26ic)
None 121 220 78
LPS 106 238 80
LBP 121 248 70
LPS-LBP 174 226 72
Stimulant Antibody
Attachment index
(EC3bi)
9
LPS - 12
LPS + LBP - 485
LPS + LBP W6/32 (10 Wg/ml) 528
LPS + LBP 3C10 (1 wg/ml) 59
LPS + LBP 3C10 (10 Fig/ml) 17surface from a preexisting intracellular pool . The cytokines
used here areknown to cause fusion ofat least three separate
intracellular pools of membrane, a compartment marked by
the presence of alkaline phosphatase (23, 24), a compartment
marked by CR1 (25, 26), and specific granules marked by
CR3 (25-30) . Fusion of the compartment containing alka-
line phosphatase occurs at concentrations of agonist lower
than are required for fusion ofCR1- or CR3-containing mem-
branous compartments (26) and lower than are required for
expression ofCD14 (Fig . 1) . In direct comparisons, the time
ofincubation and concentration of agonists required for up-
regulation of CD14 were identical with those required for
upregulation of CR1 and CR3 (P.A . Detmers and A .
Jakubowski, unpublished observations) . Thus, CD14 is un-
likely to reside in the easily mobilized alkaline phosphatase
compartment and is more likely to reside in a compartment
shared byCR1 or CR3 . However, since these latter two com-
partments show similar responses to agonists, our data do
not distinguish which contains the CD14 .
We show here that CD14 on the surface ofPMN is capable
ofbinding particles opsonized withLPS-LBP complexes (Table
2) . Exposure ofPMN to stimulatory cytokines, with subse-
quent increases in the expression of CD14, enhances this ability
to recognize LPS-LBP complexes. Thus,CD14 on PMN may
play a role in the clearance of Gram-negative bacteria, and
cytokinesmay augment this clearance mechanism . It should
be noted, however, that binding of LPS-LBP complexes to
CD14 represents only one of several mechanisms to clearLPS.
Dispersions ofLPS may be directly recognized by the scav-
enger receptor (also known as the acetyl-LDL receptor) (31),
and LPS-bearing particlesmay be directly recognized byCD18
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molecules (18, 32) . PMN possess two of these mechanisms
(CD18 and CD14), and each may serve in binding ofbacteria
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In addition to its function as an opsonic receptor, CD14
plays an important role in initiating the responses of leuko-
cytes to LPS. LPS-LBP complexes stimulated a dramatic in-
crease in the adhesive activity of CR3 (Figs. 3 and 4), and
this response was completely blocked by anti-CD14 mAbs .
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as LBP are a vital part of the normal process for responding
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